![Mark Winderlich](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Winderlich
Företagsledare/Principal på
HOOA PHARPAR
Profil
Mark Winderlich is currently the Chief Development Officer at HOOKIPA Pharma, Inc. He previously worked at Evotec SE as the EVP & Global Head-Scientific Operations.
Dr. Winderlich holds a graduate degree from Heidelberg University (Ohio) and a doctorate degree from Max-Planck-Institute for Molecular Genetics.
Aktiva positioner av Mark Winderlich
| Företag | Position | Start |
|---|---|---|
| HOOA PHARPAR | Företagsledare/Principal | 2024-04-01 |
Tidigare kända positioner av Mark Winderlich
| Företag | Position | Slut |
|---|---|---|
| EVOTEC SE | Företagsledare/Principal | - |
Mark Winderlichs utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
12
Första gradens relationer
4
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 4 |
|---|---|
Evotec SE
 Evotec SE Miscellaneous Commercial ServicesCommercial Services Provides drug discovery and development services | Commercial Services |
Heidelberg University (Ohio)
 Heidelberg University (Ohio) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Max-Planck-Institute for Molecular Genetics
 Max-Planck-Institute for Molecular Genetics Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
HOOKIPA Pharma, Inc.
 HOOKIPA Pharma, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company which develops pharmaceutical products for immunotherapeutics targeting infectious diseases and cancers | Health Technology |
